# Jürgen Schumacher

> Jürgen Schumacher is a seed investor backing Biotechnology and Manufacturing. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 2
- Last investment: May 2017
- Lead investor: 0%
- Last updated: Aug 2026

Jürgen Schumacher is a renowned entrepreneur. Jürgen co-founded QIAGEN in 1984 and served as member of Quiagen´s management board until 1993. Later he co-founded Evotec, Vivoscience, Algiax Pharmaceuticals as well as other biotech and life science companies. Jürgen has more than 35 years experience in the industry and is a member of numerousbiotech associations and is a consultant for the biotechnology activities of North Rhine Westphalia.

## Contacts

5 contacts available for Jürgen Schumacher: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/jrgen-schumacher?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 50% |
| Manufacturing | 1 | 50% |
| Pharmaceutical | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Numaferm | NUMAFERM challenges this paradigm. We have developed a reliable, cost-efficient manufacturing process that enables the reduction of production costs dramatically (up to 1000x). How is it possible? Our process is based on a well-designed microorganism that converts simple nutrients to peptides. It is the first-in-place bioprocess that serves as areliable platform for the production of peptides; independent of their sequence, length or functionality. |  | Seed | May 13, 2017 | http://numaferm.com/ |
| AudioCure Pharma | AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of drug candidates. He is joined by highly skilled scientists and executives as well as atight-knit network of academic partners, internationally renowned advisors and strategic investors.AudioCure is based in Berlin, Germany. Their office is located in a peaceful courtyard in the central area of Mitte. As such, they benefit from being within easy reach of the main train station and many other Berlin high-tech companies and universities while also enjoying the hustle and bustle of this vibrant capital city. They have close ties to the Charité University which allows for a close interaction with the experts of this world renowned institution. Their front-runner compound: AC102, is currently in late stage preclinical development for the treatment of acute noise-induced hearing loss having successfully demonstrated preclinical proof of concept in 2016. |  | Seed | May 29, 2012 | https://www.audiocure.com |

2 of 2 investments shown.

## Co-investors
- [Evonik Venture Capital](https://shizune.co/investors/profile/evonik-venture-capital-gmbh) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors in Germany](https://shizune.co/investors/biotech-angel-investors-germany)
- [Biotechnology Angel Investors in Germany](https://shizune.co/investors/biotechnology-angel-investors-germany)
- [Climate Angel Investors in Germany](https://shizune.co/investors/climate-angel-investors-germany)

## FAQ

### What does Jürgen Schumacher invest in?

Jürgen Schumacher invests primarily in Biotechnology, Manufacturing and Pharmaceutical startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Jürgen Schumacher?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Jürgen Schumacher last invest?

The most recent investment recorded for Jürgen Schumacher closed in May 2017. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co